Literature DB >> 8260249

Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.

A M Nouri1, R F Hussain, R T Oliver, A M Handy, I Bartkova, J G Bodmer.   

Abstract

Tissue sections from 22 seminoma (Se) and 10 teratoma (Te) patients were investigated for correlation between the presence of tumour infiltrating T-lymphocytes (TIL) and the expression of major histocompatibility complex (MHC) antigens using an immunoperoxidase staining technique. Complete absence of both class I and II antigens was observed in all Te and 20 out of 22 Se. The two positive Se showed only weak expression on 2% of tumour cells. Despite the absence of human leucocyte antigens (HLA) there were a large number of TIL scattered throughout the tissues in the case of Se with no predominance of CD4 or CD8 subpopulations in either group. T gamma positive cells were less than 5% of total CD3 positive cells in both Se and Te. The majority of the TIL were found to express activation markers, i.e. HLA class II antigens. Culture of tumour cell suspension with IL-2 produced passageable IL-2-dependent T cells from 10 out of 15 tumours. Studies with testis cell lines showed the complete absence of class I antigens in 2 out of 5 cases and the inability of interferon gamma (IFN gamma) to induce expression. IFN gamma also failed to induce class II antigens in three out of five of these lines. The immunological paradox of the presence of a large number of activated T-cells in testicular tumours despite the complete absence of MHC antigens remains unexplained and needs further investigation. Possible hypotheses are reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260249     DOI: 10.1016/0959-8049(93)90545-q

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation.

Authors:  P Chomez; R Williams; O De Backer; T Boon; B Vennström
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Immunopathology of in situ seminoma.

Authors:  B Bols; L Jensen; A Jensen; O Braendstrup
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

3.  Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade.

Authors:  J C Rockett; S J Darnton; J Crocker; H R Matthews; A G Morris
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

4.  Natural immunity to pluripotency antigen OCT4 in humans.

Authors:  Kavita M Dhodapkar; Darren Feldman; Phillip Matthews; Soroosh Radfar; Roxana Pickering; Stefan Turkula; Henry Zebroski; Madhav V Dhodapkar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

5.  Pituitary and systemic autoimmunity in a case of intrasellar germinoma.

Authors:  Angelika Gutenberg; Jennifer J Bell; Isabella Lupi; Shey-Cherng Tzou; Melissa A Landek-Salgado; Hiroaki Kimura; Jack Su; Lefkothea P Karaviti; Roberto Salvatori; Patrizio Caturegli
Journal:  Pituitary       Date:  2009-05-26       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.